GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Microfluidic Models of Metastatic Cancer

$304,106
Gary D Luker · University Of Michigan At Ann Arbor · R01 · FY2012 · CA

Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer

$304,046
Brooke L Fridley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA

Project 2: Physical Mechanisms and Clinical Implications of Mechano-transduction

$304,043
Ravi Radhakrishnan · University Of Pennsylvania · U54 · FY2015 · CA

Project 4 - Study of KSHV Carcinogenesis

$303,998
Dirk P Dittmer · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA

Anti-tumor Immunity in Myeloma

$303,993
Madhav V Dhodapkar · Yale University · R01 · FY2013 · CA

Mechanisms of Immune-mediated Tumor Cell Destruction

$303,991
Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

The Role of the Stem Cell Niche in ALL

$303,988
Laura F Gibson · West Virginia University · R01 · FY2010 · CA

The Role of the Stem Cell Niche in ALL

$303,988
Laura F Gibson · West Virginia University · R01 · FY2009 · CA

The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis

$303,948
Denise C Connolly · Research Inst Of Fox Chase Can Ctr · R01 · FY2013 · CA

Nanostructured Matrices for Cancer Cell Biology

$303,940
Milan Mrksich · Northwestern University At Chicago · U54 · FY2010 · CA

Inflammation in Breast Cancer Initiation and Promotion

$303,925
Kathryn L Schwertfeger · University Of Minnesota · R01 · FY2014 · CA

The chemical biology of pharmacological ascorbate in cancer treatment

$303,925
Garry R Buettner · University Of Iowa · R01 · FY2014 · CA

Project 4 - Study of KSHV Carcinogenesis

$303,916
Dirk P Dittmer · Univ Of North Carolina Chapel Hill · P01 · FY2017 · CA

Discovery and Development of Natural Products for Interception of CRC

$303,875
Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · UG3 · FY2024 · CA

Discovery and Development of Natural Products for Interception of CRC

$303,875
Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · UG3 · FY2025 · CA

CANCAN - ROCHESTER

$303,872
Karen M Mustian · University Of Rochester · OT2 · FY2023 · CA

Vascular Leukocytes influence the tumor microenvironment

$303,810
Jose R Conejo-Garcia · Dartmouth College · R01 · FY2007 · CA

Vascular Leukocytes influence the tumor microenvironment

$303,810
Jose R Conejo-Garcia · Dartmouth College · R01 · FY2008 · CA

Vascular Leukocytes influence the tumor microenvironment

$303,810
Jose R Conejo-Garcia · Dartmouth College · R01 · FY2009 · CA

Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion

$303,798
David L Bartlett · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA

The Role of CD4+ T Cells in Antitumor Immunity

$303,797
Rongfu Wang · Methodist Hospital Research Institute · R01 · FY2012 · CA

Project 1: Treatment of GBM using an oncolytic HSV engineered to improve immunogenic tumor destruction

$303,659
Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2025 · CA

Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression

$303,650
Ken S Lau · Vanderbilt University Medical Center · U54 · FY2023 · CA

Biology of Tumor-Stroma Interaction

$303,635
Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2009 · CA

Enhancing immune therapy in pancreatic cancer by targeting IL-6

$303,623
Gregory B. Lesinski · Emory University · R01 · FY2021 · CA